Reconstruction Outcomes in Immediate Post-mastectomy Breast Reconstruction With ADM
Public ClinicalTrials.gov record NCT03145337. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Randomized, Multi-Center Clinical Study Comparing Outcomes in Patients Undergoing Prosthetic, Acellular Dermal Matrix (ADM) Assisted, Immediate Post-Mastectomy Breast Reconstruction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Evaluation and comparison of clinical and aesthetic outcomes associated with the use of two allograft dermal matrices (ADMs) currently in use for tissue assisted immediate post-mastectomy breast reconstruction.
Study identification
- NCT ID
- NCT03145337
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2017
- Primary completion
- Jan 31, 2019
- Completion
- Apr 30, 2019
- Last update posted
- Sep 18, 2018
2017 – 2019
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwestern University Medical Center | Chicago | Illinois | 60611 | — |
| NorthShore Health Systems | Evanston | Illinois | 60062 | — |
| Louisiana State Health Science Center | New Orleans | Louisiana | 70115 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Faulkner Brigham & Women's Hospital | Jamaica Plain | Massachusetts | 02130 | — |
| New York University Langone Medical Center | New York | New York | 10017 | — |
| Harris Methodist Southlake Hospital | Fort Worth | Texas | 76104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Breast Reconstruction trials
Other public records listing Breast Reconstruction. Sorted by last update posted; newest first. Not a recommendation.
- NCT06575192: Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult Participants Recruiting
- NCT02724371: A Study of the Safety and Effectiveness of the Mentor Larger Size MemoryGel Ultra High Profile Breast Implants in Subjects Who Are Undergoing Primary Breast Reconstruction or Revision Reconstruction Active, not recruiting
- NCT07670754: ORASIS in Breast Reconstruction Not yet recruiting
- NCT04891510: A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery Recruiting
- NCT07135596: Effectiveness and Safety of OviTex® PRS in Breast Reconstruction Recruiting
- NCT05585710: Pulsed Lavage in Implant-Based Breast Reconstruction Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03145337, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2018 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03145337 live on ClinicalTrials.gov.